State of New Jersey Common Pension Fund D’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-26,606	Closed	-$2.71M	–	1679
2023 Q2	$2.71M	Buy	+26,606	New	+$2.52M	0.01%	1094
2022 Q1	–	Sell	-31,294	Closed	-$825K	–	1800
2021 Q4	$825K	Buy	31,294 +5,510	+21%	+$426K	﹤0.01%	1716
2021 Q3	$2.59M	Sell	25,784 -4,204	-14%	-$493K	0.01%	1441
2021 Q2	$4.24M	Buy	29,988 +10,098	+51%	+$1.14M	0.01%	822
2021 Q1	$1.98M	Buy	19,890 +975	+5%	+$114K	0.01%	1568
2020 Q4	$2.34M	Sell	18,915 -2,732	-13%	-$359K	0.01%	1398
2020 Q3	$2.11M	Buy	21,647 +5,022	+30%	+$627K	0.01%	1285
2020 Q2	$2.59M	Buy	16,625 +2,151	+15%	+$327K	0.01%	986
2020 Q1	$2.09M	Hold	14,474	–	–	0.01%	1004
2019 Q4	$2.96M	Buy	+14,474	New	+$2.64M	0.01%	1027

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

State of New Jersey Common Pension Fund D's RETA Position: Q3 2023 in Review

State of New Jersey Common Pension Fund D sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 26,606 shares — an estimated $2.71M sold.

State of New Jersey Common Pension Fund D first reported a position in RETA in Q4 2019 and held it in 10 quarters. The position peaked at $4.24M in Q2 2021. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

State of New Jersey Common Pension Fund D reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
State of New Jersey Common Pension Fund D sold 26,606 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.71M.
State of New Jersey Common Pension Fund D first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2019 and held it in 10 quarters.
State of New Jersey Common Pension Fund D's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $4.24M in Q2 2021.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q3 2023, filed 8 Nov 2023.